Xenotropic murine leukemia virus-related virus-associated chronic fatigue syndrome reveals a distinct inflammatory signature

In Vivo

Volumn 25, Issue 3, 2011, Pages 307-314

  Lombardi, Vincent C ^a   Hagen, Kathryn S ^a   Hunter, Kenneth W ^a   Diamond, John W ^b   Smith Gagen, Julie ^a   Yang, Wei ^a   Mikovits, Judy A ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b Triad Medical Center   (United States)

Author keywords

Chemokine; CSF cytokine; Random forest; XMRV

Indexed keywords

ALPHA INTERFERON; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RANDOM FOREST; SENSITIVITY AND SPECIFICITY; XENOTROPIC MULV RELATED VIRUS;

EID: 79956357538     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Klimas NG and Koneru AO: Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Curr Rheumatol Rep 9: 482-487, 2007. (Pubitemid 350305206)
2. Chia JK and Chia AY: Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol 61: 43-48, 2008. (Pubitemid 351158224)
3. Kerr JR, Burke B, Petty R, Gough J, Fear D, Mattey DL, Axford JS, Dalgleish AG and Nutt DJ: Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes. J Clin Pathol 61: 730-739, 2008. (Pubitemid 351859965)
4. Sterzl I and Zamrazil V: Endocrinopathy in the differential diagnosis of chronic fatigue syndrome. Vnitr Lek 42: 624-626, 1996.
5. Ross SD, Estok RP, Frame D, Stone LR, Ludensky V and Levine CB: Disability and chronic fatigue syndrome: a focus on function. Arch Intern Med 164: 1098-1107, 2004. (Pubitemid 38668989)
6. Schluederberg A, Straus SE, Peterson P, Blumenthal S, Komaroff AL, Spring SB, Landay A and Buchwald D: NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann Intern Med 117: 325-331, 1992.
7. Choppa PC, Vojdani A, Tagle C, Andrin R and Magtoto L: Multiplex PCR for the detection of Mycoplasma fermentons, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Mol Cell Probes 12: 301-308, 1998.
8. Klimas NG, Salvato FR, Morgan R and Fletcher MA: Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 28: 1403-1410, 1990. (Pubitemid 20194439)
9. Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL and Ritz J: Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 139: 3306-3313, 1987. (Pubitemid 18021981)
10. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW and Bleijenberg G: Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38: 383-392, 1994. (Pubitemid 24188056)
11. De Meirleir K, Suhadolnik RJ, Lebleu B and Englebienne P: Antiviral pathway activation in chronic fatigue syndrome and acute infection. Clin Infect Dis 34: 1420-1421; author reply 1421-1422, 2002.
12. Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Muller WE, Schroder HC, Carter WA et al: Up-regulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1): S96-104.
13. Mao H, Tu W, Liu Y, Qin G, Zheng J, Chan PL, Lam KT, Peiris JS and Lau YL: Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol 84: 4148-4157, 1994.
14. Ho JW, Hershkovitz O, Peiris M, Zilka A, Bar-Ilan A, Nal B, Chu K, Kudelko M, Kam YW, Achdout H, Mandelboim M, Altmeyer R, Mandelboim O, Bruzzone R and Porgador A: H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol 82: 2028-2032, 2008. (Pubitemid 351206948)
15. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR and Whitman JE: Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 16: 179-191, 2000.
16. Beqaj SH, Lerner AM and Fitzgerald JT: Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol 61: 623-626, 2008. (Pubitemid 351678216)
17. Lerner AM, Beqaj SH, Deeter RG and Fitzgerald JT: IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo 18: 101-106, 2004.
18. Levine PH, Fears TR, Cummings P and Hoover RN: Cancer and a fatiguing illness in Northern Nevada - a causal hypothesis. Ann Epidemiol 8: 245-249, 1998. (Pubitemid 28208942)
19. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W and Trent J: Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30: 181-184, 2002.
20. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH and DeRisi JL: Identification of a novel gamma-retrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25, 2006.
21. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH and Mikovits JA: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science, pp. 585-589, 2009.
22. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, Wang R and Alter HJ: Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci USA 107: 15874-15879, 2010.
23. Nowroozalizadeh S, Mansson F, da Silva Z, Repits J, Dabo B, Pereira C, Biague A, Albert J, Nielsen J, Aaby P, Fenyo EM, Norrgren H, Holmgren B and Jansson M: Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections. Cytokine 46: 325-331, 2009.
24. Dhib-Jalbut S, Hoffman PM, Yamabe T, Sun D, Xia J, Eisenberg H, Bergey G and Ruscetti FW: Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells. Ann Neurol 36: 787-790, 1994. (Pubitemid 24337640)
25. Natelson BH, Weaver SA, Tseng CL and Ottenweller JE: Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin Diagn Lab Immunol 12: 52-55, 2005.
26. Chao CC, Gallagher M, Phair J and Peterson PK: Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis 162: 1412-1413, 1990.
27. Fulton RJ, McDade RL, Smith PL, Kienker LJ and Kettman JR Jr.: Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 43: 1749-1756, 1997.
28. Miller JE, Wilson SS, Jaye DL and Kronenberg M: An automated semiquantitative B- and T-cell clonality assay. Mol Diagn 4: 101-117, 1999. (Pubitemid 29326130)
29. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M and Macintyre EA: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317, 2003. (Pubitemid 38072572)
30. van Krieken JH, Langerak AW, Macintyre EA, Kneba M, Hodges E, Sanz RG, Morgan GJ, Parreira A, Molina TJ, Cabecadas J, Gaulard P, Jasani B, Garcia JF, Ott M, Hannsmann ML, Berger F, Hummel M, Davi F, Bruggemann M, Lavender FL, Schuuring E, Evans PA, White H, Salles G, Groenen PJ, Gameiro P, Pott C and Dongen JJ: Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21: 201-206, 2007. (Pubitemid 46158110)
31. Breiman L: Random Forests. Mach Learn 45: 5-32, 2001.
32. Curnow SJ, Falciani F, Durrani OM, Cheung CM, Ross EJ, Wloka K, Rauz S, Wallace GR, Salmon M and Murray PI: Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 46: 4251-4259, 2005. (Pubitemid 44264629)
33. Hata N, Sato M, Takaoka A, Asagiri M, Tanaka N and Taniguchi T: Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus. Biochem Biophys Res Commun 285: 518-525, 2001. (Pubitemid 32918101)
34. Taniguchi T and Takaoka A: A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2: 378-386, 2001.
35. Lusso P, Garzino-Demo A, Crowley RW and Malnati MS: Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med 181: 1303-1310, 1995.
36. Vrsalovic MM, Korac P, Dominis M, Ostojic S, Mannhalter C and Kusec R: T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Vrsalovic Barr virus in angioimmunoblastic T-cell lymphoma. Hematol Oncol 22: 169-177, 2004.
37. Aoyagi M, Shimojo N, Sekine K, Nishimuta T and Kohno Y: Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells. Clin Exp Immunol 131: 312-317, 2003.
38. Holtmeier W and Kabelitz D: γ-δ-T-Cells link innate and adaptive immune responses. Chem Immunol Allergy 86: 151-183, 2005.
39. Jason J, Buchanan I, Archibald LK, Nwanyanwu OC, Bell M, Green TA, Eick A, Han A, Razsi D, Kazembe PN, Dobbie H, Midathada M and Jarvis WR: Natural T, γδ, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections. J Infect Dis 182: 474-481, 2000. (Pubitemid 30651044)
40. + T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer. J Immunother 32: 310-321, 2009.
41. Gu Y, Shore, RE, Arslan AA, Koenig KL, Liu M, Ibrahim S, Lokshin AE and Zeleniuch-Jacquotte A: Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control 21: 1323-1333, 2010.